Iran Daru (XTEH:IRDR1) EV-to-EBIT : (As of Jun. 14, 2024)

View and export this data going back to 1990. Start your Free Trial

What is Iran Daru EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Iran Daru's Enterprise Value is IRR0.00 Mil. Iran Daru does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Iran Daru's EV-to-EBIT at this moment.

The historical rank and industry rank for Iran Daru's EV-to-EBIT or its related term are showing as below:

XTEH:IRDR1's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Iran Daru's Enterprise Value for the quarter that ended in . 20 was IRR0.00 Mil. Iran Daru does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Iran Daru's Earnings Yield (Joel Greenblatt) % at this moment.

Iran Daru EV-to-EBIT Historical Data

The historical data trend for Iran Daru's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru EV-to-EBIT Chart

Iran Daru Annual Data

Trend

EV-to-EBIT

Iran Daru Semi-Annual Data

EV-to-EBIT

Competitive Comparison of Iran Daru's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Iran Daru's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Iran Daru's EV-to-EBIT falls into.

Iran Daru EV-to-EBIT Calculation

Iran Daru's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.000	/
	=

Iran Daru (XTEH:IRDR1) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Iran Daru's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 )	=	EBIT	/	Enterprise Value (Q: . 20 )
	=		/
	=	%

Iran Daru EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Iran Daru's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111

Website

https://www.irandaru.com

Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines